New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
08:05 EDTKERXKeryx announces marketing approval of ferric citrate in Japan
Keryx announced that its Japanese partner, Japan Tobacco has received manufacturing and marketing approval of ferric citrate from the Japanese Ministry of Health, Labour and Welfare. Under the license agreement with JT and Torii, within 30 days, Keryx will receive a non-refundable payment of $10M for the achievement of the marketing approval milestone. Keryx will also receive double-digit tiered royalties on net sales of Riona in Japan, as well as up to an additional $55M upon the achievement of certain annual net sales milestones.
News For KERX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
09:24 EDTKERXOn The Fly: Pre-market Movers
Subscribe for More Information
08:52 EDTKERXKeryx CFO to leave company by October
Keryx Biopharmaceuticals disclosed in a regulatory filing a planned consolidation of its finance and accounting function into its Boston office and that its CFO, James Oliviero, will be leaving Keryx by October. In connection with this transition, the company entered into an employment agreement with Oliviero that became effective on February 26 and will terminate on October 1, but may be extended upon the mutual agreement of the parties. The company has commenced a search for a new CFO who will be based in its Boston office. Oliviero will continue to manage the company’s finance and accounting team during the remainder of his tenure and will assist in the transition of his duties to the new CFO, Keryx said.
07:14 EDTKERXKeryx reports Q4 EPS (44c), consensus (37c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use